+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Treatment of chronic urticaria with a beta2-adrenergic stimulant



Treatment of chronic urticaria with a beta2-adrenergic stimulant



Clinical Allergy 7(1): 35-39



Twenty-four patients with chronic utricaria resistant to conventional therapy were treated orally with terbutaline, a specific beta2 stimulant. This therapy was much more effective than antihistamines. At the dose of 1-25 mg three times a day, there were few side effects. The efficacy was independent of the IgE levels; it seemed greater in idiopathic cases than in cholinergic or pressure induced urticaria.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 041852082

Download citation: RISBibTeXText

PMID: 872355

DOI: 10.1111/j.1365-2222.1977.tb01422.x


Related references

Effect of long term beta-1-adrenergic receptor stimulant treatment on cardiac adrenergic function in chronic heart failure As assessed using MIBG-TL dual SPECT. Japanese Circulation Journal 58(7): 461, 1994

Evaluation of a new beta2 adrenergic receptor stimulant, terbutaline, in bronchospasm. III. Aerosol administration. Current Therapeutic Research, Clinical and Experimental 18(3): 425-432, 1975

Comparison of two oral selective beta2-adrenergic stimulant drugs in bronchial asthma. British Medical Journal 1(5750): 637-639, 1971

Metabolic fate of a new beta2-adrenergic stimulant procaterol (OPC-2009). Absorption, distribution, metabolism and excretion in the beagle dog. Arzneimittel-Forschung 29(2): 261-265, 1979

The beta2-adrenergic receptor agonists in the treatment of chronic obstructive pulmonary disease. Przeglad Lekarski 62(7): 724-728, 2006

Tolerance to or facilitation of pharmacological effects induced by chronic treatment with the beta-adrenergic stimulant clenbuterol. Journal of Neural Transmission 62(1-2): 65-76, 1985

Potentiating effect of beta-adrenergic stimulant on the response of the cutaneous vascular resistance to alpha-adrenergic stimulant. Experientia 31(5): 552-554, 1975

Attenuation of insulin resistance by chronic beta2-adrenergic agonist treatment possible muscle specific contributions. Life Sciences 69(5): 599-611, 2001

Beta2-adrenergic receptor antagonists protect against ventricular fibrillation: in vivo and in vitro evidence for enhanced sensitivity to beta2-adrenergic stimulation in animals susceptible to sudden death. Circulation 96(6): 1914-1922, 1997

Megaesophagus in an asthmatic patient and beta2 stimulant treatment by inhalation. Biomedicine & PharmacoTherapy 58(3): 194-195, 2004

Live cell imaging of Gs and the beta2-adrenergic receptor demonstrates that both alphas and beta1gamma7 internalize upon stimulation and exhibit similar trafficking patterns that differ from that of the beta2-adrenergic receptor. Journal of Biological Chemistry 279(42): 44101-44112, 2004

Beta2-Adrenergic agonists suppress rat autoimmune myocarditis: potential role of beta2-adrenergic stimulants as new therapeutic agents for myocarditis. Circulation 114(9): 936-944, 2006

Chronic Inducible Urticaria (CIndU) versus Chronic Spontaneous Urticaria (CSU): Can new names and new updated information improve our care for patients with urticaria?. Asian Pacific Journal of Allergy and Immunology 34(2): 95-97, 2017

Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid. Clinical and Experimental Allergy 31(10): 1607-1614, 2001